Watch CTTH. Know when insiders buy.
One email the day a filing lands. Free.
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2015 · Sep 30 | — | — | — | — | −$342K | — | -0.03 | −$16K | — | — | Nov 23 |
| Q2 2015 · Jun 30 | — | — | — | — | −$363K | — | 0.00 | −$29K | — | — | Nov 18 |
| Q1 2015 · Mar 31 | — | — | — | −$337K | −$337K | — | -0.02 | −$40K | — | — | Nov 12 |
| Q4 2014 · Dec 31derived | — | — | — | — | −$629K | — | -0.03 | −$47K | — | — | Nov 23 |
| Q3 2014 · Sep 30 | — | — | — | — | −$43K | — | -0.01 | −$24K | — | — | Nov 23 |
| Q2 2014 · Jun 30 | — | — | — | −$22K | −$920 | — | 0.00 | −$29K | — | — | Nov 18 |
| Q1 2014 · Mar 31 | — | — | — | −$2K | −$2K | — | 0.00 | −$330 | — | — | Nov 12 |
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2014 · to Dec 31 | — | — | −$672K | −$672K | — | -0.04 | −$72K | — | — | — | — |
Every number comes from CTT PHARMACEUTICAL HOLDINGS, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.